Business
Overview

Health Food Business

Our technological capabilities allow us to develop high-quality products in various dosage forms ranging from general health foods centered on supplements to foods with functional claims. Our newly established Nanryo Factory is one of the largest soft capsule manufacturing plants in Japan and provides us with the capacity for growth on demand. This provides us with a strong competitive advantage where we can scale production in line with our customer’s needs.

  • ■Business model

    Contract Development Manufacturing Organization (CDMO)
  • ■Products/applications

    Consumer products, final products, health foods, foods
  • ■Formulation/capsule technology/dosage form

    Tablets, granulated powder, hard capsules, soft capsules, seamless capsules
  • See related pages

New Applications Business

At Sunsho Pharmaceutical, we leverage our varied capsule technologies to further innovate our product offerings. Recently our “flavor capsules” have experienced rapid growth and interest.
These seamless capsules are filled with flavor materials that release when crushed during usage. Our knowledge of capsule technology enables us to develop new applications across a variety of fields, including intermediate goods, daily necessities, industrial products, and sustenance products.

  • ■Business model

    Manufacture and sale of in-house products
  • ■Products/applications

    Intermediate goods, raw material processing, flavor capsules
  • ■Formulation/capsule technology/dosage form

    Seamless capsules
  • See related pages

Pharmaceuticals

As a CDMO specializing in pharmaceutical softgel capsules, we provide comprehensive end‑to‑end services spanning formulation development, clinical trial material manufacturing, and commercial-scale production. Our integrated support covers every stage of the development and manufacturing process, including formulation and process design, prototyping, GMP compliant manufacturing, quality control, and quality assurance. By leveraging our technical expertise and operational capabilities, we deliver optimal, tailored solutions to meet each client’s specific requirements. Within our facilities, we have a dedicated area to produce pilot-scale investigational drugs using softgel capsule technology. This enables seamless continuity from formulation development through to clinical trial material manufacturing. We are further advancing this platform with a view toward future commercial-scale production. We support the entire product lifecycle from development to stable, long-term supply under a quality system aligned with regulatory requirements in Japan, the United States, and Europe. In parallel, we continue to advance the development our proprietary technology, UniORV®.

  • ■Business model

    Contract Development and Manufacturing (CDMO)
  • ■Products, Intended Applications

    Pharmaceuticals, Investigational Drugs
  • ■Formulation, Encapsulation Technology, Drug Delivery Form

    Pharmaceutical Softgel Capsules
    Pharmaceutical Seamless Softgel Capsules
    UniORV®
  • See related pages